Q2:23 Thematic Earnings Roundup
This earnings season has provided us with insights into how various publicly traded healthcare companies are navigating the current landscape. Let’s delve into the trends and outcomes that defined the second quarter of 2023. The Home Health & Hospice Market: The Erosion of Medicare Fee-For-Service The Home Health & Hospice (HH&H) market has been volatile of late, with companies like Amedisys Inc. (NASDAQ: AMED) reporting a significant shortfall in earnings and a decline in revenue compared to the same period last year. Amedisys reported a financial loss in the second quarter of $80.3 million, after reporting a profit in the same 2022 period. A significant portion of this... Read More »
The Managed Care Earnings Round-Up
Some of the largest Managed Care providers in the world have announced their earnings for 2022, and the results are looking promising for the Managed Care space. Humana Inc., Centene Corporation and Cigna Corp. all achieved positive operating and financial results for 2022, with some even surpassing their expectations for the year. However, M&A within the Managed Care sector slowed in 2022, with just 43 transactions announced, a 10.4% decrease from 2021 when 48 deals were announced. This decline is the result of a shift in these company’s growth strategy as they focus on cleaning up their portfolios through divestments. Humana Inc. (NYSE:HUM) Humana reported strong operating and... Read More »
Centene Corporation and Magellan Health Merge
It looks like the healthcare M&A market is off to a strong start for the new year. Centene Corporation (NYSE: CNC), the multi-national managed care giant, has announced the acquisition of Magellan Health, Inc. (NASDAQ: MGLN), a healthcare management company specializing in behavioral health and pharmacy benefits. The deal is valued at $2.2 billion, or $95 per share, a 14.6% premium to Magellan’s closing price of $82.85 on December 31, 2020. Magellan Health has approximately 23.5 million members enrolled under its programs. Once the news broke, Magellan’s shares jumped 11% while Centene’s stock reported a slight uptick. Magellan generated annualized EBITDA of... Read More »
Centene Corporation Adds Digital Health Analytics Firm
Centene Corporation (NYSE: CNC), the managed care giant, has acquired Apixio Inc. to boost its healthcare analytics capabilities. Terms of the deal were not disclosed. San Mateo, California-based Apixio provides a technology suite that mines, compiles and analyzes large volumes of disparate, unstructured patient data (such as physician notes and medical charts), and creates and refines algorithms to extract high-quality insights to support payers’ and providers’ administrative activities. Apixio’s AI platform has been trained to handle the complexities and challenges of the healthcare industry and deliver proven results. Apixio will remain an operationally independent entity as part of... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
